Skip to main content
Top
Published in: BMC Infectious Diseases 1/2023

Open Access 01-12-2023 | Septicemia | Research

Epidemiology of neonatal sepsis in two neonatal intensive care units in Krakow, Poland in 2016–2017 years

Authors: Edyta Golińska, Ł Kozień, A Tomusiak-Plebanek, J Kędzierska, M Dorycka, R Lauterbach, D Pawlik, B Rzepecka-Węglarz, M Janiszewska, PB Heczko, J Wojkowska-Mach, M Strus

Published in: BMC Infectious Diseases | Issue 1/2023

Login to get access

Abstract

Background

Sepsis in low-birth-weight neonates remains one of the most significant causes of neonatal morbidity and mortality. Approximately 3 million newborns suffer from sepsis globally every year. The aim of this study was to compare demographic and clinical features, as well as etiology and antibiotic susceptibility, of the main pathogens related to neonatal sepsis in two neonatal intensive units during a two-year period.

Methods

We observed early-onset (EO-BSI) and late-onset bloodstream infections (LO-BSI) cases in two high-reference neonatal intensive care units (NICU) over a 24-month period (2016–2017). Samples of patients’ blood were tested for the presence of the microorganisms. All bacterial isolates were tested for susceptibility to antibiotics.

Results

The majority of sepsis cases weighed above 1000 g and were born by cesarean section. About 10% of the EO-BSI group died. There were differences in the EO-BSI /LO-BSI ratio in the compared wards due to differences among the admitted children. The most common pathogens isolated from blood were coagulase-negative staphylococci (CoNS) were represented by two dominating species: S. epidermidis and S. haemolyticus, followed by Klebsiella spp. strains and E.coli, which were mostly found in EO-BSI cases. No single S. agalactiae (GBS) strain was isolated. The majority of CoNS strains were resistant to methicillin, half were resistant to aminoglycosides, and one-third were resistant to macrolides and lincosamides. Half of the Gram-negative rods were resistant to beta-lactams.

Conclusions

The epidemiology of sepsis in two observed NICUs is comparable to data obtained from other studies with a predominance of methicillin-resistant CoNS in LO-BSI and beta-lactam resistant E. coli in EO-BSI. It is of importance that the campaign for controlling GBS carriage in pregnant women in Poland resulted in the disappearance of GBS as a cause of sepsis. Unfortunately, there are no such measures to control E.coli related sepsis.
Literature
1.
go back to reference Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018;6(3):223–30.CrossRefPubMed Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018;6(3):223–30.CrossRefPubMed
2.
go back to reference Cortese F, Scicchitano P, Gesualdo M, et al. Early and late Infections in newborns: where do we stand? A review. Pediatr Neonatol. 2016;57(4):265–73.CrossRefPubMed Cortese F, Scicchitano P, Gesualdo M, et al. Early and late Infections in newborns: where do we stand? A review. Pediatr Neonatol. 2016;57(4):265–73.CrossRefPubMed
3.
go back to reference McCracken GH Jr. Group B Streptococci: the new challenge in neonatal Infections. J Pediatr J Pediatr. 1973;82(4):703–6.CrossRefPubMed McCracken GH Jr. Group B Streptococci: the new challenge in neonatal Infections. J Pediatr J Pediatr. 1973;82(4):703–6.CrossRefPubMed
4.
go back to reference Jones B, Peake K, Morris AJ et al. 558 Escherichia Coli: a growing problem in early onset neonatal Sepsis. 2004;44. Jones B, Peake K, Morris AJ et al. 558 Escherichia Coli: a growing problem in early onset neonatal Sepsis. 2004;44.
5.
go back to reference Cordero L, Rau R, Taylor D, et al. Enteric gram-negative bacilli bloodstream Infections: 17 years’ experience in a neonatal intensive care unit. Am J Infect Control. 2004;32(4):189–95.CrossRefPubMed Cordero L, Rau R, Taylor D, et al. Enteric gram-negative bacilli bloodstream Infections: 17 years’ experience in a neonatal intensive care unit. Am J Infect Control. 2004;32(4):189–95.CrossRefPubMed
6.
go back to reference Marchant EA, Boyce GK, Sadarangani M et al. Neonatal sepsis due to coagulase-negative staphylococci. Clin Dev Immunol. 2013;2013. Marchant EA, Boyce GK, Sadarangani M et al. Neonatal sepsis due to coagulase-negative staphylococci. Clin Dev Immunol. 2013;2013.
7.
go back to reference Blanchard AC, Quach C, Autmizguine J. Staphylococcal Infections in infants: updates and current challenges. Clin Perinatol. 2015;42(1):119–32.CrossRefPubMed Blanchard AC, Quach C, Autmizguine J. Staphylococcal Infections in infants: updates and current challenges. Clin Perinatol. 2015;42(1):119–32.CrossRefPubMed
8.
go back to reference Xu Z, Shah HN, Misra R et al. The prevalence, antibiotic resistance and mecA characterization of coagulase negative staphylococci recovered from non-healthcare settings in London, UK. Antimicrob Resist Infect Control. 2018;7(1). Xu Z, Shah HN, Misra R et al. The prevalence, antibiotic resistance and mecA characterization of coagulase negative staphylococci recovered from non-healthcare settings in London, UK. Antimicrob Resist Infect Control. 2018;7(1).
9.
10.
go back to reference Dong Y, Speer CP. The role of Staphylococcus epidermidis in neonatal sepsis: guarding angel or pathogenic devil? Int J Med Microbiol. 2014;304(5–6):513–20.CrossRefPubMed Dong Y, Speer CP. The role of Staphylococcus epidermidis in neonatal sepsis: guarding angel or pathogenic devil? Int J Med Microbiol. 2014;304(5–6):513–20.CrossRefPubMed
11.
go back to reference Gastmeier P, Geffers C, Schwab F, et al. Development of a surveillance system for nosocomial Infections: the component for neonatal intensive care units in Germany. Int J Med Microbiol. 2004;57(2):126–31. Gastmeier P, Geffers C, Schwab F, et al. Development of a surveillance system for nosocomial Infections: the component for neonatal intensive care units in Germany. Int J Med Microbiol. 2004;57(2):126–31.
12.
go back to reference Leclercq R. Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Clin Infect Dis. 2002;34(4):482–92.CrossRefPubMed Leclercq R. Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Clin Infect Dis. 2002;34(4):482–92.CrossRefPubMed
13.
go back to reference Drieux L, Brossier F, Sougakoff W, et al. Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect. 2008;14:90–103.CrossRefPubMed Drieux L, Brossier F, Sougakoff W, et al. Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect. 2008;14:90–103.CrossRefPubMed
14.
go back to reference Wójkowska-Mach, Chmielarczyk S, et al. Neonate Bloodstream Infections in Organization for Economic Cooperation and Development Countries: an update on Epidemiology and Prevention. J Clin Med. 2019;8(10):1750.CrossRefPubMed Wójkowska-Mach, Chmielarczyk S, et al. Neonate Bloodstream Infections in Organization for Economic Cooperation and Development Countries: an update on Epidemiology and Prevention. J Clin Med. 2019;8(10):1750.CrossRefPubMed
15.
go back to reference Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. The Lancet. 2017;390(10104):1770–80.CrossRef Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. The Lancet. 2017;390(10104):1770–80.CrossRef
16.
go back to reference Thomas JC, Vargas MR, Miragaia M, et al. Improved multilocus sequence typing scheme for Staphylococcus epidermidis. J Clin Microbiol. 2007;45(2):616–9.CrossRefPubMed Thomas JC, Vargas MR, Miragaia M, et al. Improved multilocus sequence typing scheme for Staphylococcus epidermidis. J Clin Microbiol. 2007;45(2):616–9.CrossRefPubMed
18.
go back to reference Golińska E, Strus M, Tomusiak-Plebanek A, et al. Coagulase-negative staphylococci contained in gut microbiota as a primary source of sepsis in low-and very low birth weight neonates. J Clin Med. 2020;9(8):1–13.CrossRef Golińska E, Strus M, Tomusiak-Plebanek A, et al. Coagulase-negative staphylococci contained in gut microbiota as a primary source of sepsis in low-and very low birth weight neonates. J Clin Med. 2020;9(8):1–13.CrossRef
19.
go back to reference Corbella M, Caltagirone M, Gaiarsa S, et al. Characterization of an outbreak of extended-spectrum β-Lactamase-producing klebsiella pneumoniae in a neonatal intensive care unit in Italy. Microb Drug Resist. 2018;24(8):1128–36.CrossRefPubMedPubMedCentral Corbella M, Caltagirone M, Gaiarsa S, et al. Characterization of an outbreak of extended-spectrum β-Lactamase-producing klebsiella pneumoniae in a neonatal intensive care unit in Italy. Microb Drug Resist. 2018;24(8):1128–36.CrossRefPubMedPubMedCentral
20.
go back to reference European Centre for Disease Prevention and Control (ECDC). European Antimicrobial Resistance Surveillance Network (EARS-Net) database. Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data. European Centre for Disease Prevention and Control (ECDC). European Antimicrobial Resistance Surveillance Network (EARS-Net) database. Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data.
21.
go back to reference Stoll BJ, Puopolo KM, Hansen NI et al. Early-Onset neonatal Sepsis 2015 to 2017, the rise of Escherichia coli, and the need for Novel Prevention Strategies. JAMA Pediatr. 2020;174(7). Stoll BJ, Puopolo KM, Hansen NI et al. Early-Onset neonatal Sepsis 2015 to 2017, the rise of Escherichia coli, and the need for Novel Prevention Strategies. JAMA Pediatr. 2020;174(7).
22.
go back to reference Kotarski J, Heczko PB, Lauterbach R, et al. [Polish Gynecological Society’s recommendations regarding diagnosis and prevention of streptococcus agalactiae Infection in pregnant women and newborns]. Ginekol Pol. 2008;79(3):221–3.PubMed Kotarski J, Heczko PB, Lauterbach R, et al. [Polish Gynecological Society’s recommendations regarding diagnosis and prevention of streptococcus agalactiae Infection in pregnant women and newborns]. Ginekol Pol. 2008;79(3):221–3.PubMed
23.
go back to reference Wójkowska-Mach J, Borszewska-Kornacka M, Domańska J, Gadzinowski J, Gulczyńska E, Helwich E, Kordek A, Pawlik D, Szczapa J, Klamka J, Heczko PB. Early-onset Infections of very-low-birth-weight infants in Polish neonatal intensive care units. Pediatr Infect Dis J. 2012;31(7):691–5.CrossRefPubMed Wójkowska-Mach J, Borszewska-Kornacka M, Domańska J, Gadzinowski J, Gulczyńska E, Helwich E, Kordek A, Pawlik D, Szczapa J, Klamka J, Heczko PB. Early-onset Infections of very-low-birth-weight infants in Polish neonatal intensive care units. Pediatr Infect Dis J. 2012;31(7):691–5.CrossRefPubMed
24.
go back to reference Pham JT. Challenges of Vancomycin dosing and therapeutic monitoring in neonates. J Pediatr Pharmacol Ther. 2020;25(6):476–84.PubMedPubMedCentral Pham JT. Challenges of Vancomycin dosing and therapeutic monitoring in neonates. J Pediatr Pharmacol Ther. 2020;25(6):476–84.PubMedPubMedCentral
25.
go back to reference Murray CJ, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629–55.CrossRef Murray CJ, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629–55.CrossRef
26.
go back to reference Newton ER. Chorioamnionitis and intraamniotic Infection. Clin Obstet Gynecol. 1993;36(4):795–808.CrossRefPubMed Newton ER. Chorioamnionitis and intraamniotic Infection. Clin Obstet Gynecol. 1993;36(4):795–808.CrossRefPubMed
27.
go back to reference Puopolo KM, Benitz WE, Zaoutis TE, et al. Management of neonates born at ≤ 34 6/7 weeks’ Gestation with suspected or proven early-onset bacterial Sepsis. Pediatrics. 2018;142:6. Puopolo KM, Benitz WE, Zaoutis TE, et al. Management of neonates born at ≤ 34 6/7 weeks’ Gestation with suspected or proven early-onset bacterial Sepsis. Pediatrics. 2018;142:6.
Metadata
Title
Epidemiology of neonatal sepsis in two neonatal intensive care units in Krakow, Poland in 2016–2017 years
Authors
Edyta Golińska
Ł Kozień
A Tomusiak-Plebanek
J Kędzierska
M Dorycka
R Lauterbach
D Pawlik
B Rzepecka-Węglarz
M Janiszewska
PB Heczko
J Wojkowska-Mach
M Strus
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2023
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-023-08836-2

Other articles of this Issue 1/2023

BMC Infectious Diseases 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine